Astal Laboratories Q1 Results Total Income ₹1,383.60 Crores & Operating Profit ₹158.80 Crores

Astal Laboratories Growth Comparison 

Astal Laboratories Q1 Results: In Astral Laboratories' Q1 results for June 2024, there are some important figures to note. The company earned a total revenue of ₹1,383.60 crores, which is a decrease of 14.86% compared to the previous quarter (QoQ) of ₹1,506.20 crores. However, the revenue is up by 7.83% when compared to the same quarter last year (YoY), which was ₹1,283.10 crores. This means that even though there was a drop from the previous quarter, the company did better than it did a year ago.

Astal Laboratories’ selling, general, and administrative expenses increased by 46.94% QoQ to ₹126.70 crores from ₹86.20 crores. Compared to last year’s same quarter (YoY), these expenses were higher by 27.21% from ₹99.60 crores. Depreciation and amortization costs also went up by 24.87% QoQ, totaling ₹55.60 crores, and were 20.09% higher YoY compared to ₹46.30 crores.

Astal Laboratories’ Total operating expenses decreased by 11.64% QoQ to ₹1,224.80 crores, but increased by 8.60% YoY. The operating income fell by 33.56% QoQ to ₹158.80 crores, though it showed a slight increase of 2.25% YoY. Net income also fell by 33.70% QoQ to ₹120.40 crores, but it increased slightly by 0.50% YoY. The diluted normalized EPS fell by 33.73% QoQ to ₹4.48, while showing a small increase of 0.45% YoY.

Here's the Quarterly Financial Results for Astral for Q1:

Source: Here

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Astal Laboratories Q1 Results

Astal Laboratories has shared their unaudited financial results for the quarter ending June 30, 2024. In this period, the company earned a total revenue of ₹1,317.99 lakhs. This is made up of ₹1,314.57 lakhs from their main operations and ₹3.42 lakhs from other sources. Compared to the previous quarter (ended March 31, 2024), their revenue increased slightly from ₹1,225.25 lakhs.

Astal Laboratories' total expenses for this quarter were ₹1,084.15 lakhs. This includes costs like ₹1,159.12 lakhs for materials used and ₹33.51 lakhs for stock purchases. They also had some savings from a reduction in inventories and expenses related to employee benefits, finance costs, depreciation, and other costs. 

Despite these expenses, Astal Laboratories made a profit of ₹233.84 lakhs before accounting for exceptional items. After deducting taxes (₹62.29 lakhs for current tax and ₹2.64 lakhs for deferred tax), the company’s final profit for the quarter was ₹168.91 lakhs. This shows a significant increase from the ₹55.82 lakhs profit in the previous quarter, indicating strong performance in this quarter.

Here is the simplified financial summary for Astal Laboratories Limited for the quarter ended June 30, 2024:

(Rs. In Lakhs except Earnings per share)

Astal Laboratories Financial Metrics

The table shows key financial information about Astal Laboratories. The company has a market capitalization of ₹124 crore, which means that's the total value of all its shares combined. The current stock price is ₹126. The highest price it reached was ₹132, and the lowest was ₹32. The Price-to-Earnings (P/E) ratio is 44.9, indicating how much investors are willing to pay for each unit of earnings. The book value per share is ₹23.7, showing the value of the company's assets per share. The dividend yield is 0.00%, meaning the company doesn't pay out dividends.

Here's a summary of the company's financial data:

Quarterly Results

For Astal Laboratories, the quarterly results show significant improvement over the periods. In December 2023, the company had strong sales of ₹8.41 crores and operating profit of ₹0.49 crores with a 4.73% profit margin. By March 2024, sales rose to ₹12.25 crores, and operating profit increased to ₹0.58 crores, with a higher profit margin of 18.10%. By June 2024, sales grew further to ₹13.15 crores, and operating profit surged to ₹2.38 crores. 

Here are the quarterly results for December 2023, March 2024, and June 2024:

About Astal Laboratories 

Astal Laboratories is a company listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). It regularly reports its financial results every quarter. The company is managed by a board of directors who meet often to oversee and review the company's performance. They work closely with top management to ensure the company runs smoothly.

Investors and interested parties can find updated information about Astal Laboratories, including its share price and financial details, on financial news websites like GoodReturns. This helps stakeholders keep track of the company’s financial health and stock performance.